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Abstract Conjugated linoleic acids (CLAs) have been found
to have beneficial effects on human health when used as die-
tary supplements. However, their availability is limited be-
cause pure, chemistry-based production is expensive, and
biology-based fermentation methods can only create small
quantities. In an effort to enhance microbial production of
CLAs, four genetically modified strains of the oleaginous
yeast Yarrowia lipolytica were generated. These mutants pre-
sented various genetic modifications, including the elimina-
tion of β-oxidation (pox1-6Δ), the inability to store lipids as
triglycerides (dga1Δ dga2Δ are1Δ lro1Δ), and the overexpres-
sion of the Y. lipolytica Δ12-desaturase gene (YlFAD2) under
the control of the constitutive pTEF promoter. All strains re-
ceived two copies of the pTEF-oPAI or pPOX-oPAI expres-
sion cassettes; PAI encodes linoleic acid isomerase in
Propionibacterium acnes. The strains were cultured in
neosynthesis or bioconversion medium in flasks or a bioreac-
tor. The strain combining the three modifications mentioned
above showed the best results: when it was grown in
neosynthesis medium in a flask, CLAs represented 6.5% of
total fatty acids and in bioconversion medium in a bioreactor,
and CLA content reached 302 mg/L. In a previous study, a
CLA degradation rate of 117 mg/L/h was observed in biocon-
version medium. Here, by eliminating β-oxidation, we
achieved a much lower rate of 1.8 mg/L/h.
Keywords Conjugated linoleic acids . Oleaginous yeast .
Lipid accumulation . Yarrowia lipolytica . Metabolic
engineering
Introduction
The conjugated linoleic acid (CLA) family is large. It contains
28 isomers of linoleic acid (LA; 18:2) that all feature a conju-
gated pair of double bonds that are separated by a single car-
bon bond. The conjugated double bonds can occur in several
different positions, ranging fromC6 to C14 (6, 8; 7, 9; 8, 10; 9,
11; 10, 12; 11, 13; or 12, 14). A variety of conformers exist
(cis-cis, cis-trans, trans-cis, and trans-trans) (Banni 2002). The
most common CLAs are c9t11-C18:2 (commonly known as
rumenic acid) and t10c12-C18:2; they represent 90% of the
CLA isomers found in milk fat. Interest in these compounds
has grown ever since some CLAs were discovered to have
physiological benefits (Lehnen et al. 2015), such as providing
protection against atherosclerosis or cancer (Belury 2002;
Crumb 2011). It has also been shown that t10c12-C18:2 can
decrease body fat (De Deckere et al. 1999; Gavino et al.
2000). In the human diet, the major sources of CLAs are meat
and dairy products obtained from ruminants (Chin et al. 1992;
Shantha et al. 1994; McGuire et al. 1999). However, CLA
production by ruminal bacteria is uncommon, and CLAs are
scarce in foods. It is well known that linoleic acid isomerase
converts LA into CLAs, and the linoleic acid isomerase found
in Propionibacterium acnes (PAI) is the only enzyme with a
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enzyme uses free fatty acids as its only substrate. ThePAI gene
has been expressed in various CLA production systems, in-
cluding those involving E. coli, S. cerevisiae, Lactococcus
lactis, and tobacco and rice plants (Kishino et al. 2002;
Ando et al. 2004; Hornung et al. 2005; Kohno-Murase et al.
2006; Rosberg-Cody et al. 2007).
Yarrowia lipolytica is an oleaginous yeast that can efficiently
exploit hydrophobic substrates as its sole carbon and energy
sources, and it has been shown to be a good model for lipid
metabolism studies (Beopoulos et al. 2009b; Beopoulos and
Nicaud 2012; Ledesma Amaro et al. 2016; Ledesma Amaro
and Nicaud 2016). Past work has characterized the genes in-
volved in themost important pathways in fatty acid degradation,
triglyceride (TAG) synthesis, lipid remobilization, fatty acid
transport, and fatty acid activation (Wang et al. 1999;
Beopoulos et al. 2009a; Dulermo and Nicaud 2011;
Beopoulos et al. 2012; Dulermo et al. 2014; Ledesma Amaro
et al. 2016; LedesmaAmaro andNicaud 2016). These pathways
and their associated genes have been targets in studies focused
on the development of obese Y. lipolytica strains, which can
display lipid accumulation levels that exceed 80% of cell dry
weight (CDW); the goal was to create an alternative strain for
biofuel production (Beopoulos et al. 2008; Dulermo and Nicaud
2011). This species has also been used to produce rare fatty acids
(Ledesma Amaro and Nicaud 2016) and has the advantage of
being recognized as a safe-to-use microorganism (Groenewald
et al. 2014). The most advanced process developed to date is the
production of ώ3 fatty acids by DuPont-engineered Y. lipolytica
strains (Zhu et al. 2015; Xie et al. 2015).
Two of the main target pathways for genetic manipulations
areβ-oxidation and TAG synthesis. Degradation of fatty acids
in Y. lipolytica takes place exclusively via β-oxidation in per-
oxisomes. Six acyl-CoA oxidases (Aox1–6, encoded by the
POX1–POX6 genes, respectively) catalyze the first step.
These acyl-CoA oxidases exhibit different activities and sub-
strate specificities, as demonstrated by successive gene disrup-
tion (Wang et al. 1999). Two acyl-CoA oxidases, Aox2p and
Aox3p, have high activity levels and display substrate speci-
ficity for long-chain and short-chain fatty acids, respectively.
A strain in which all six genes were deleted (pox1-6Δ) was
unable to grow on lipid substrates and could not degrade fatty
acids (Wang et al. 1999; Dulermo and Nicaud 2011).
Lipid storage depends on a key step in the synthesis of
TAGs from diacylglycerol (DAG), which involves three
DAG acytransferases (Dga1p, Dga2p, and Lro1p). TAGs can
be synthesized by the acyl-CoA-dependent reaction catalyzed
byDga1p andDga2p or by the acyl-CoA-independent pathway
catalyzed by the phospholipid:diacylglycerol acyltransferase
Lro1p. Moreover, Y. lipolytica possesses a sterol acyltransfer-
ase—acyl-CoA:cholesterol acyltransferase Are1p—that is not
involved in TAG synthesis (Beopoulos et al. 2012). Strains
from which all three DAG acyltransferases (Q3; dga1Δ
dga2Δ lro1Δ) or all four acyltransferases (Q4; dga1Δ dga2Δ
lro1Δ are1Δ) were deleted could not store TAGs and had high
levels of free fatty acids in their cells (Beopoulos et al. 2009b).
Strains that are incapable of carrying out fatty acid degradation
and lipid synthesis (pox1-6ΔQ3 fad2Δ; pox1-6Δ dga1Δ dga2Δ
lro1Δ are1Δ fad2Δ) have been used as chassis strains for
ricinoleic acid production. The endogenous FAD2,
YALI0B10153g, coding for the Δ12 desaturase catalyzing the
transformation of oleic acid to linoleic acid, has also been de-
leted from these strains (Beopoulos et al. 2014).
Yeast-based CLA production was first explored using
S. cerevisiae (Hornung et al. 2005) that expressed the PAI
gene. By exploiting a codon-optimized version of the gene
(oPAI), researchers were able to achieve an eightfold in-
crease in CLA production. More recently, Zhang and col-
leagues (Zhang et al. 2012, 2013) evaluated CLA produc-
tion in Y. lipolytica. In a first study (Zhang et al. 2012),
which used the wild-type (WT) PAI gene, CLAs represent-
ed 0.2% of total fatty acids. However, yield was then im-
proved by the insertion of multiple copies (up to 24) of
oPAI: the percentage of t10c12-C18:2 reached 5.9% when
neosynthesis medium was used. Unfortunately, the multi-
copy strains were shown to be unstable. Subsequently, re-
searchers combined a stronger promoter for oPAI expres-
sion (hp16d, a derivative of the hp4d promoter) with the
coexpression of the Δ12 desaturase native to Mortierella
alpina (under the control of hp4d and present in multiple
copies). After the yeast strains were incubated for 38.5 h in
a bioreactor, CLAs represented 10% of total fatty acids and
0.4% of CDW when neosynthesis medium (containing glu-
cose) was used and 44% of total fatty acids and 30% of
CDW when bioconversion medium (containing soybean
oil) was used. However, the CLAs rapidly degraded
(<10 h). When the yeast strains were incubated in flasks
instead, CLA content did not surpass 45 mg/L (Zhang et al.
2013). This rapid degradation suggests that an optimal
Y. lipolytica genetic background for CLA biosynthesis re-
mains to be discovered.
In this study, we explored the outcome of genetic mod-
ifications to Y. lipolytica lipid metabolism pathways (β-
oxidation and TAG synthesis) with a view to improving
CLA production. We introduced two copies of oPAI into
four strains with different genetic backgrounds and then
analyzed CLA production under different conditions: in
neosynthesis versus bioconversion medium and in flasks
versus a bioreactor.
Methods
Yeast strains and culture conditions
The Y. lipolytica strains used were derived from the WT strain
W29 (ATCC 20460). They are described in Table 1, and their
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construction is depicted in Fig. 1. The medium and growth
conditions used for E. coli are described elsewhere
(Sambrook et al. 1989), as are those for Y. lipolytica (Barth
and Gaillardin 1996).
Rich medium (YPD), minimal glucose medium (YNB),
and minimal medium with leucine (YNBleu) or uracil
(YNBura) were prepared as per Mlícková et al. (2004).
Flask and bioreactor neosynthesis medium (YED5) contained
0.5% (w/v) yeast extract (Fisher Scientific, Illkirch
Graffenstaden, France) and 5% (w/v) glucose (Cargill, Saint-
Germain-en-Laye, France). The bioconversion media—
linoleic acid (LA) flask medium (YNBD1-LA2) and soybean
oil (SO) bioreactor medium (YNBD1-SO2)—contained
0.17% (w/v) yeast nitrogen base (without amino acids and
ammonium sulfate: YNBw/w; Difco, Paris, France); 0.15%
(w/v) yeast extract (Fisher Scientific, Illkirch Graffenstaden,
France); 1% (w/v) glucose (Cargill, Saint-Germain-en-Laye,
France); 0.5% (w/v) NH4Cl (VWR, Fontenay-Sous-Bois,
France); 0.5 M phosphate buffer (pH 6.8); and either 2% (v/
v) LA (67% purity; Sigma, Saint Louis, Missouri, USA) or 2%
(v/v) SO (62% purity; Carrefour, France). The emulsion of LA
and SO at 20% was sonicated for three cycles of 1 min on ice
(fatty acid 10 mL, H2O 10 mL, Tween 80 0.05% (v/v)). The
fatty acid composition of the LA was 4% C16:0, 2% C18:0,
30% C18:1, and 62% C18:2; that of the SO was 13% C16:0,
6% C18:0, 24% C18:1, and 57% C18:2.
Shake flask cultures were carried out in 250-mL baffled
flasks containing 50 mL of each culture medium and incubat-
ed at 28 °C with stirring (160 rpm) for 72 h. The pH of the
culture was adjusted to 6 for neosynthesis medium and 6.8 for
bioconversion medium. Culture in 5-L bioreactor (TRYTONI,
Pierre Guérin, Niort, France) was performed with a working
volume of 3.5 L at 28 °C, aeration rate of 1 vvm, and agitation
speed of 700 rpm.
General genetic techniques
Genomic DNAwas extracted from recombinant yeast clones as
described elsewhere (Hoffman andWinston 1987) and used for
PCR amplification. Amplified fragments were purified with the
QIAgen Purification Kit (Qiagen, Hilden, Germany). Digested
DNA fragments were subject to electrophoresis and recovered
from 1% agarose gels using the QIAquick TM Gel Extraction
Kit (Qiagen, Hilden, Germany). The restriction enzymes were
obtained from Eurogentec SA (Liége, Belgium), and the DNA
polymerase GO Taq came from Promega (Promega, Madison,
WI, USA). Yeast cells were transformed using the lithium ac-
etate method (Gaillardin et al. 1985).
Table 1 Strains and plasmids used in this study
Strains Plasmid, genotype References
E. coli
DH5a 80dlacZΔm15, recA1, endA1, gyrA96, thi-1, hsdR17 (rk-, mk+),
supE44, relA1, deoR, Δ(lacZYA-argF)U169
Promega
JME547 (DH5a) pUB4-Cre1 (Cre ARS68 Hyg in) This study
JME1514 (DH5a) JMP62–pPOX-oPAI-URA3ex This study
JME1519 (DH5a) JMP62-pTEF-oPAI-URA3ex This study
JME1516 (DH5a) JMP62–pPOX-oPAI-LEU2ex This study
JME1517 (DH5a) JMP62-pTEF-oPAI-LEU2ex This study
JME1346 (DH5a) JMP62-pTEF-FAD2-LEU2ex This study
Y. lipolytica
JMY195 (Po1d) MATA ura3-302 leu2-270 xpr2-322 Barth and Gaillardin (1996)
JMY1233 (pox1-6Δ) Po1d, pox1-6Δ Beopoulos et al. (2008)
JMY1877 (Q4) Po1d, dga1Δ dga2Δ lro1Δ are1Δ Beopoulos et al. (2012)
JMY2159 (pox1-6Δ, Q3, fad2Δ) Po1d, pox1-6Δ dga1Δ dga2Δ lro1Δ fad2Δ Beopoulos et al. (2014)
JMY3325 Po1d, pox1-6Δ dga1Δ dga2Δ lro1Δ fad2Δ, pTEF-FAD2-LEU2 This study
JMY3326 Po1d, pox1-6Δ dga1Δ dga2Δ lro1Δ fad2Δ, pTEF-FAD2 This study
JMY2746, CLIB 3036 Po1d; pPOX-oPAI-LEU2ex, pPOX-oPAI-URA3ex This study
JMY2756, CLIB 3037 pox1-6Δ; pPOX-oPAI-LEU2ex, pPOX-oPAI-URA3ex This study
JMY3473, CLIB 3038 Q4; pTEF-oPAI-LEU2ex, pTEF-oPAI-URA3ex This study
JMY3479, CLIB 3039 pox1-6Δ, Q3, fad2Δ, pTEF-FAD2; pTEF-oPAI-LEU2ex, pTEF-oPAI-URA3ex This study
Strains were deposited at the French CIRM-Levures collection under CLIB number
(http://www6.inra.fr/cirm_eng/Yeasts)
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Plasmid construction and marker excision
Excision of the LEU2ex and URA3ex markers was performed
with the replicative plasmid pRRQ2 (JME547) using the Cre-
lox recombination system as described by Fickers et al. (2003).
Genes of interest were placed under the control of either the
constitutive TEF promoter or the OA-induced POX promoter.
Briefly, the coding sequence was inserted between the BamHI-
AvrII restriction sites of the vector, which was derived from
JMP62 and contained the pTEF or pPOX promoter and the
LEU2ex or URA3ex selective marker (Fig. 1). To change the
selective marker in the vector, the I-SceI cloning endonuclease
site was used. Plasmids were linearized with NotI and the ex-
pression cassettes were purified after gel electrophoresis prior to
transformation. Primers used for gene amplification and strain
verification are described in Table 2.
Determination of biomass
Biomass was quantified using cell dry weight (CDW). The
culture medium was centrifuged at 8000 rpm (772.6 g) for
10 min. The pellet was washed once with distilled water for
neosynthesis medium and twice with BSA 0.5% and once with
NaCl 0.9% for bioconversion culture medium, and its mass
(i.e., weight) was determined after it was freeze-dried overnight.
Lipid analysis
The lipids from 20 mg of freeze-dried cultured cells were
directly converted into methyl esters, which were analyzed
via gas chromatography (GC), as described in Browse et al.
(1986). The GC analysis was performed using a GC-2010
Plus apparatus (Shimadzu, France) equipped with a flame
ionization detector. A BPX 70G1203 column (30 m,
0.25 mm, 0.25 μm; SGE Analytical Science, Europe) was
used to characterize the fatty acid methyl esters (FAMEs).
They were identified via comparison to commercial standards
(CLA, CLA methyl ester, FAME37, Supelco; Sigma, Saint
Louis, Missouri), and their levels were quantified using an
internal standard—100 μg of commercial C17:0 (Sigma,
Saint Louis, Missouri, USA).
Results
Construction of recombinant yeast strains
Zhang and colleagues showed that CLA production could be
enhanced by using codon-optimized PAI, the strong promoter
hp16d, and the defective marker ura3d4 (Zhang et al. 2012,
2013); the latter was developed in our laboratory for multiple
Fig. 1 Schematic representation of strain construction. The auxotrophic
strain Po1d (Leu−Ura−) was derived from WT strain W29. The
construction of strains JMY195 (auxotrophic WT), JMY1233 (pox1-
6Δ), JMY1877 (dga1Δ dga2Δ lro1Δ are1Δ [Q4]), and JMY2159
(pox1-6Δ dga1Δ lro1Δ dga2Δ fad2Δ) are described elsewhere (Barth
and Gaillardin 1996; Beopoulos et al. 2008, 2012, 2014). The gray boxes
contain intermediary strains, and the blue boxes contain study strains.
Marker excision was performed with the replicative plasmid pUB4-CreI
(pRRQ2). For FAD2 and oPAI overexpression, coding genes were
expressed under the pTEF or pPOX promoter in the vector JMP62 con-
taining either the URA3ex or LEU2ex excisable auxotrophic markers
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copy integration. However, they also found that gene expres-
sion and CLA production were mutant dependent and that
their strains were unstable (Zhang et al. 2012, 2013). In this
study, we wanted to compare outcomes when different genetic
backgrounds were used, which meant we could not exploit
hp16d or the ura3d4 system. However, we did use oPAI,
expressed under either the strong pTEF or pPOX2 promoter;
we introduced two copies using either the URA3 or the LEU2
marker (Table 1).
Four different genetic backgrounds were used: (1)
JMY195 (the auxotrophic WT strain Po1d); (2) JMY1233
(pox1-6Δ), which has six disrupted acyl-CoA oxidase
genes and is thus unable to degrade fatty acids via β-
oxidation (Beopoulos et al. 2008); (3) JMY1877 (Q4),
from which genes for four acyltransferases—Dga1p,
Dga2p, Lro1p, and Are1p—were deleted and which was
thus unable to synthesize TAGs (Beopoulos et al. 2012);
and (4) JMY3326 (pox1-6Δ dga1Δ dga2Δ lro1Δ fad2Δ,
pTEF-FAD2), which was derived from JMY2159 (pox1-
6Δ, Q3, fad2Δ). In JMY2159 (pox1-6Δ, Q3, fad2Δ),
genes related to β-oxidation (pox1-6Δ) and TAG synthesis
(dga1Δ dga2Δ lro1Δ), as well as the Δ12-desaturase gene
(FAD2), were deleted (Beopoulos et al. 2008). To create
JMY3326, JMY2159 was first transformed with a copy
of the Y. lipolytica FAD2 gene expressed under the pTEF
promoter; this process gave rise to JMY3325 (Fig. 1,
Table 1). Second, the URA3 marker was rescued upon
transformation with the replicative plasmid pUB4 as de-
scribed in the BMethods^ section, giving rise to JMY3326.
Two copies of oPAI were introduced into these four
genetic backgrounds, giving rise to the prototroph strains
JMY2746 (Po1d-oPAI), which represented the WT geno-
type; JMY2756 (pox1-6Δ-oPAI), which could not perform
β-oxidation; JMY3473 (Q4-oPAI), which could not syn-
thesize TAGs; and JMY3479 (pox1-6Δ-Q3-FAD2-oPAI),
which could neither perform β-oxidation nor synthesize
TAGs but which overexpressed Δ12 desaturase, the en-
zyme responsible for converting OA (18:1) to LA (18:2)
(Fig. 1). Hereafter, JMY2746, JMY2756, JMY3473, and
JMY3479 will be referred to as Po1d, pox1-6Δ, Q4, and
pox1-6Δ-Q3-FAD2, respectively.
Initial culturing conditions
The four study strains were first cultivated in flasks in
either neosynthesis medium—where they were given
50 g/L glucose (YED5) as their carbon source—or in bio-
conversion medium—where they were given 20 g/L LA
(YNBD1LA2) as their carbon source. Since some strains
were incapable of β-oxidation (the pox1-6Δ genotype),
10 g/L of glucose was added to the bioconversion medi-
um to allow growth.
Lipid and CLA production dynamics depend on genetic
background
Production in neosynthesis medium
When yeasts were grown in the neosynthesis medium, lipid
accumulation patterns varied according to genetic background
(Fig. 2). First, we focused on the effects of eliminating β-
oxidation. After 72 h of culture, in the Po1d-oPAI WT
(JMY2746) and the pox1-6Δ-oPAI strain (JMY2756), lipids
accounted for 19.0 ± 0.9% and 23.2 ± 0.5% of CDW, respec-
tively. In contrast, in the Q4-oPAI strain (JMY3473) and the
pox1-6Δ-Q3-FAD2-oPAI strain (JMY3479), lipids represented
just 7.0 ± 0.1% and 8.0 ± 0.1% of CDW, respectively
(Fig. 2a). As for CLA production, in the Po1d-oPAI WT
(JMY2746) and the pox1-6Δ-oPAI strain (JMY2756), CLAs
accounted for 0.4 ± 0.1% and 0.5 ± 0.1% of total fatty acids,
respectively. Thus, the removal of β-oxidation resulted in a
21% increase in total lipid production and a 25% increase in
CLA production. However, in relative terms, CLA production
remained rather limited.
We then looked at the effects of eliminating TAG synthesis,
a drastic decrease in lipid content was observed in the relevant
strains: 7.0% of CDW in the Q4-oPAImutant (JMY3473) and
8.2% of CDW in the pox1-6Δ-Q3-FAD2-oPAI mutant
(JMY3479). CLAs accounted for 1.5 ± 0.1% and 6.5 ± 0.1%
of total fatty acids, respectively. Thus, the elimination of TAG
synthesis resulted in a major increase in CLA production: it
was threefold greater in the Q4-oPAI mutant (JMY3473), but
it was nearly 15-fold greater in the pox1-6Δ-Q3-FAD2-oPAI
Table 2 Primers used in this study








mutant (JMY3479), which also could not perform β-
oxidation and which overexpressed FAD2.
Fatty acid profiles also varied according to genetic back-
ground (Fig. 2b). The Po1d-oPAIWT (JMY2746) mainly ac-
cumulated OA (18:1), which represented about 60 ± 0.3% of
total fatty acids; in contrast, this number was around 10% for
LA (18:2). However, in the Q4-oPAI strain (JMY3473), OA
and LA levels were similar (28 and 34%, respectively). A
different pattern was seen in the pox1-6Δ-Q3-FAD2-oPAI
strain (JMY3479): LA accounted for 55% of total fatty acids,
which meant there was more substrate for PAI. Indeed, in this
strain, LA-to-OA ratio was about 6.5, while it was 1.5 in the
Q4-oPAI strain (JMY3473) and just 0.2 in the other two
strains. These numbers mean there was a 32.5-fold difference
between the Po1d-oPAIWT (JMY2746) and the pox1-6Δ-Q3-
FAD2-oPAI mutant (JMY3479).
For the pox1-6Δ-oPAI strain (JMY2756), we observed a
small gain in lipid content that seemed to come at the expense
of biomass production (Fig. 2c). As seen elsewhere (Wang
et al. 1999), it would seem that the absence of β-oxidation
affects growth and biomass production without affecting total
lipid levels in this strain. Maximum CLA content (52 mg/L)
was seen in the pox1-6Δ-Q3-FAD2-oPAI strain (JMY3479)
after 72 h of culture (Fig. 2d); the production rate was
0.8 mg/L/h. CLA content was slightly higher in the pox1-
6Δ-oPAI strain (JMY2756) than in either the Po1d-oPAI WT
(JMY2746) or the Q4-oPAI strain (JMY3473).
Production in bioconversion medium
When the yeast was cultured in linoleic acid bioconversion
medium, there were clear differences in lipid production
among strains. The Po1d-oPAI WT (JMY2746) and the
pox1-6Δ-oPAI strain (JMY2756) had significantly higher
levels of lipid production than did the Q4-oPAI strain
(JMY3473) or the pox1-6Δ-Q3-FAD2-oPAI strain
(JMY3479). Indeed, in the former two strains, lipids repre-
sented 33 ± 0.9% and 37 ± 0.6% of CDW, respectively, while
in the latter two strains, lipids made up just 18.8 ± 0.2% and
22.2 ± 0.5% of CDW, respectively (Fig. 3a). After 72 h of
culture, CLAs represented 1.9 ± 0.4%, 2.7 ± 0.1%,
7.3 ± 0.1%, and 5 ± 0.1% of total fatty acids in the Po1d-
oPAI WT (JMY2746), the pox1-6Δ-oPAI strain (JMY2756),
the Q4-oPAI strain (JMY3473), and the pox1-6Δ-Q3-FAD2-
oPAI strain (JMY3479), respectively (Fig. 3a). Comparing the
results for the pox1-6Δ-oPAI strain (JMY2756) with those for
the Po1d-oPAIWT (JMY2746), it is clear that the elimination
of β-oxidation led to a 12% increase in lipid production and a
42% increase in CLA production. However, in relative terms,
CLA production still remained low.
Fig. 2 Strain production
dynamics in neosynthesis
medium in flasks. a Lipid
production expressed as a
percentage of CDW (light gray)
and CLA production expressed as
a percentage of total fatty acids
(% TFA; dark gray). b Relative
fatty acid composition (% TFA). c
Biomass in terms of CDW (g/L;
dark gray) and lipid content (g/L;
light gray). d CLA production
(mg/L). The results presented are
the mean values ± SD for two
independent biological replicates







The strains incapable of synthesizing TAGs displayed a
decrease in lipid content: 18.8 and 22.2% for the Q4-oPAI
strain (JMY3473) and the pox1-6Δ-Q3-FAD2-oPAI strain
(JMY3479), respectively. However, their levels of CLA pro-
duction were higher; CLAs represented 7.3 and 5% of total
fatty acids, respectively. Thus, when the results were com-
pared to those for the Po1d-oPAIWT (JMY2746), eliminating
TAG synthesis resulted in a more than fourfold increase in
CLA production in the Q4-oPAI strain (JMY3473) and an
almost threefold increase in CLA production in the pox1-6Δ-
Q3-FAD2-oPAI strain (JMY3479).
All the strains contained higher percentages of LA (18:2)
because of its inclusion in the medium (Fig. 3b). LA
accounted for approximately 53 ± 0.5% of total fatty acids
in the Po1d-oPAI WT (JMY2746), the pox1-6Δ-oPAI strain
(JMY2756), and the pox1-6Δ-Q3-FAD2-oPAI strain
(JMY3479) and OAwas 26.9 ± 0.7%. In the Q4-oPAI strain
(JMY3473), LA and OA, respectively, represented
42 ± 0.1% and 32 ± 0.1% of total fatty acids. The CLA-
to-LA ratio in the Q4-oPAI strain (JMY3473) was twofold
higher that in the pox1-6Δ-Q3-FAD2-oPAI strain
(JMY3479) (0.2 vs. 0.1) and fourfold higher than that in
the Po1d-oPAI WT (JMY2746) or the pox1-6Δ-oPAI strain
(JMY2756) (0.2 vs. 0.05), indicating CLA production was
the best in the Q4-oPAI strain (JMY3473), where CLAs
made up 7.3% of total fatty acids.
When considering biomass and lipid content (Fig. 3c), a
slight decrease in biomass production was observed for the
pox1-6Δ-oPAI strain (JMY2756), which meant its lipid con-
tent (about 4.8 g/L) was almost equivalent to that of the
Po1d-oPAI WT (JMY2746). In the pox1-6Δ-Q3-FAD2-
oPAI strain (JMY3479), biomass, lipid content, and CLA
content were all low. This strain also had a much slower
growth rate than the other strains (data not shown). This
strain displayed decreased viability after 48 h of culture
(data not shown). Indeed, strains unable to degrade lipids
via β-oxidation or store them as TAGs are more sensitive to
free fatty acids, therefore affecting conversion of LA into
CLAs. The LA thus remained in cells in the form of free
fatty acids. Although the strain overexpressed Δ12
desaturase, its CLA production was low. In contrast, CLA
content reached 177 mg/L in the Q4-oPAI strain (JMY3473)
(Fig. 3d)—the maximum for the four strains—which trans-
lated to a production rate of 2.5 mg/L/h.
As compared to the neosynthesis medium, the bioconver-
sion medium led to increases in lipid production of 73, 61,
168, and 170% for the Po1d-oPAIWT (JMY2746), the pox1-
6Δ-oPAI strain (JMY2756), the Q4-oPAI strain (JMY3473),
and the pox1-6Δ-Q3-FAD2-oPAI strain (JMY3479), respec-
tively. CLA production increased by 375, 440, and 386% for
the Po1d-oPAI WT (JMY2746), the pox1-6Δ-oPAI strain
(JMY2756), and the Q4-oPAI strain (JMY3473), but de-
creased by 30% for the pox1-6Δ-Q3-FAD2-oPAI strain
(JMY3479), suggesting the latter did not convert the LA in
the medium into CLAs. It would have remained in the form of
free fatty acids and could thus have had a toxic effect.
Fig. 3 Strain production
dynamics in bioconversion
medium (LA) in flasks. a Lipid
production expressed as a per-
centage of CDW (light gray) as
well as CLA production
expressed as a percentage of total
fatty acids (% TFA; dark gray). b
Relative fatty acid composition
(% TFA). c Biomass in terms of
CDW (g/L; dark gray) and lipid
content (g/L; light gray). d CLA
production (mg/L). The results
presented are the mean
values ± SD for two independent
biological replicates for the fol-
lowing strains: JMY2746 (Po1d-
oPAI), JMY2756 (pox1-6Δ-




Effects of Δ12 desaturase overexpression on CLA
production in a bioreactor
Further experimentation was carried out using the pox1-6Δ-
Q3-FAD2-oPAI strain (JMY3479). It was cultured in a biore-
actor in neosynthesis medium for 72 h. Biomass, lipid content,
and CLA content were determined every 24 h after inocula-
tion. Lipid levels were analyzed using GC-FID. The results
are shown in Fig. 4.
In the pox1-6Δ-Q3-FAD2-oPAI strain (JMY3479),
Y. lipolytica’s native Δ12 desaturase was disrupted (fad2Δ),
and then a single copy was reintroduced under the control of
the constitutive pTEF promoter, leading to the enzyme over-
expression. This modification increased the availability of LA,
which is the substrate for PAI. After 72 h of culture in
neosynthesis medium in the bioreactor, the strain’s CLA con-
tent was six times greater than the CLA content observed in
the other strains during growth in neosynthesis medium in
flasks. Biomass increased over time, reaching 6 g/L after
72 h; a slight increase in lipid content was also observed
(Fig. 4a). CLA content also increased over time, from
81 mg/L at 24 h to 180 mg/L at 72 h (Fig. 4b). When
neosynthesis medium was used, bioreactor culturing led to a
50% increase in lipid production (8 ± 0.1% in flasks vs.
12 ± 0.1% in the bioreactor) and a more than 345% increase
in CLA content (52 mg/L in flasks vs. 180 mg/L in the
bioreactor). In addition, the overexpression ofΔ12 desaturase
had an effect on CLA production. Over time, there was a
decrease in LA (Fig. 4c, d) and an increase in CLAs. OA
was the predominant fatty acid (59 ± 1.3% of total fatty acids)
found in the Po1d-oPAI WT (JMY2746), while LA made up
61 ± 2.2% of total fatty acids in the pox1-6Δ-Q3-FAD2-oPAI
strain (JMY3479) after 24 h of culture. The speed at which LA
was converted to CLA (2.2 mg/L/h) was equal to the speed at
which CLAs appeared (2.3 mg/L/h). Taken together, these
results confirm that LA should be used as the main substrate
for CLA production.
Effects of soybean-oil medium on CLA production
dynamics in a bioreactor
We also explored the possibility of using a vegetable oil to
replace pure LA as the carbon source during the fermentation.
More specifically, we conducted an experiment in which we
used SO, which is rich in LA (57% of total fatty acids), instead
of pure LA. We once again used the pox1-6Δ-Q3-FAD2-oPAI
strain (JMY3479): it was cultured in a 5-L bioreactor with
YNBD-SO medium containing 2% (v/v) SO.
After 96 h of culture, lipid and CLA levels had
climbed, and they represented 40 and 5.2% (w/w) of
CDW, respectively (Fig. 5a). Cellular levels of OA and
LA increased and then decreased over time (Fig. 5b),
Fig. 4 JMY3479 production
dynamics in neosynthesis
medium in a bioreactor. a
Biomass in terms of CDW (g/L;
in gray) and lipid content (g/L; in
black). bCLA production (mg/L).
c Fatty acid composition as
percentage of total fatty acids (%
TFA). d Fatty acid content (mg/
L). JMY3479 (pox1-6Δ-Q3-
FAD2-oPAI) displayed neither β-
oxidation activity nor TAG syn-
thesis but overexpressed Δ12
desaturase (YlFAD2). The results
presented are the mean
values ± SD for two independent
biological replicates
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indicating that OA was being converted to LA by Δ12
desaturase and then that LA was transformed into CLAs
by PAI. After 96 h of culture, cellular CLA content
reached 235 mg/L (Fig. 5b). The lipid content of the cul-
ture medium decreased from 20 g/L to zero over the first
96 h of culture (Fig. 5c), indicating that the SO was
completely assimilated during fermentation (Fig. 5c).
The CLA content of the culture medium built up, peaked
at 53 h of culture, and then gradually declined (Fig. 5c).
Over the first 96 h of culture, LA’s representation among
the total fatty acids decreased from 58 to 47% in cells and
from 56 to 34% in the culture medium (C18:2; Table 3).
In contrast, over that same period, the relative percentage
of CLAs increased from 0.2 to 6% in cells and from 0 to
3.4% in the culture medium. In absolute terms, CLA
levels were at 302 mg/L after 96 h of culture in YNBD-
SO medium in the bioreactor; this amount was six times
higher than that obtained when the same strain was grown
in flasks in neosynthesis medium (52 mg/L) or bioconver-
sion medium (46 mg/L). It is also twice as large as the
amount obtained when the strain was grown in a bioreac-
tor in neosynthesis medium (180 mg/L).
CLAs accumulated in cells at a rate of 3.1 mg/L/h
between 29 and 96 h of culture (Fig. 5a); for the culture
medium, the rate was 1.2 mg/L/h between 0 and 53 h
(Fig. 5c). CLA degradation in cells occurred at a rate of
1.8 mg/L/h; it began at 36 h and continued until the end
of culturing, at 160 h. In the culture medium, degradation
was rapid between 53 and 72 h (1.8 mg/L/h) and then
subsequently slowed significantly (0.2 mg/L/h) until the
end of culturing, at 160 h.
Discussion
The broad objective of this study was to metabolically engi-
neer strains of the oleaginous yeast Y. lipolytica to express
linoleic acid isomerase native to Propionibacterium acnes
and thus efficiently produce CLAs. We examined CLA pro-
duction in neosynthesis versus bioconversion medium and in
flasks versus a bioreactor.
Our first step was to compare CLA production by four
genetically modified strains grown in neosynthesis and
bioconversion media (either containing just glucose for
neosynthesis medium or glucose supplemented with LA
Fig. 5 JMY3479 production
dynamics in soybean-oil medium
in a bioreactor. a Lipid and CLA
production (% of CDW) andCLA
production in cells (g/L). b Oleic
acid (OA), linoleic acid (LA), and
CLA production of cells (g/L). c
Lipid, oleic acid (OA), linoleic
acid (LA), and CLA production
of the culture medium (g/L).
JMY3479 (pox1-6Δ-Q3-FAD2-
oPAI) displayed neither β-
oxidation activity nor TAG syn-
thesis but overexpressed Δ12
desaturase (YlFAD2). All the re-
sults presented are the mean
values ± SD for two independent
biological replicates
Table 3 Fatty acid composition of the cellular and extracellular lipids
produced by JMY3479 (pox1-6Δ-Q3-FAD2-oPAI) in soybean-oil medi-
um. Numbers represent the percentage of total fatty acids
Fatty
acids
In cells In culture medium
0 h 96 h 160 h 0 h 96 h
C16:0 10.9 ± 0.2 12.7 ± 0.6 15.6 ± 1.1 13.2 ± 0.7 24.2 ± 0.5
C16:1 0.02 ± 0.5 0.3 ± 1 0.45 ± 0.9 ND 7.1 ± 1
C18:0 3.4 ± 1.5 4.5 ± 0.7 7.6 ± 2 6.6 ± 1.7 10.7 ± 0.9
C18:1 25.1 ± 1.3 28.1 ± 2 33.5 ± 1.5 23.7 ± 0.7 16.2 ± 2
C18:2 58 ± 0.2 47.5 ± 1.4 34 ± 1 56.5 ± 1.8 34.5 ± 0.8
CLAs 0.2 ± 0.1 6 ± 0.2 5.4 ± 0.4 ND 3.4 ± 0.1
ND not detected
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as the carbon source for bioconversion medium). In
neosynthes is medium, the pox1 -6Δ -oPAI s t ra in
(JMY2756) accumulated more lipids than did the Po1d-
oPAI WT (JMY2746) (Fig. 2a), a pattern attributable to
the elimination of β-oxidation in the former. This finding
matches those of Dulermo and Nicaud (2011), who found
that lipid and TAG accumulation were improved in a β-
oxidation-deficient strain. Furthermore, Beopoulos et al.
(2008) showed that, after 24 h of culture in glucose min-
imal medium, total fatty acid accumulation was over twice
as high for a strain incapable of β-oxidation than for the
wild-type strain. These results indicate that the six acyl-
CoA oxidases play a significant role in lipid mobilization,
as had been observed by Wang et al. (1999). Since the
pox1-6Δ-oPAI strain (JMY2756) was unable to degrade
lipids, these lipids accumulated as TAGs or persisted as
free or CoA-activated fatty acids; this fact may explain
the low levels of CLA production in this strain. Lipid
and TAG accumulation patterns were also determined
for the Q4-oPAI strain (JMY3473) and the pox1-6Δ-Q3-
FAD2-oPAI strain (JMY3479). In contrast to the Po1d-
oPAI WT (JMY2746) and the pox1-6Δ-oPAI strain
(JMY2756), their relative levels of lipid accumulation
were just 7 and 8%, respectively.
These results show the important role of the four
acyltransferases in the synthesis of storage lipids, which was
also demonstrated in Beopoulos et al. (2012). Compared to
other strains, the pox1-6Δ-Q3-FAD2-oPAI strain (JMY3479),
from which three acyltransferases and six acyl-CoA oxidases
were eliminated and which overexpressed Δ12 desaturase,
produced a relatively higher percentage of CLAs (6.5% of
total fatty acids) after 72 h of culture. In this study, we intro-
duced two copies of the oPAI gene and obtained a CLA pro-
duction rate of 0.8 mg/L/h and amaximumCLA content value
of 52 mg/L. In contrast, using eight copies of the oPAI gene,
Zhang et al. (2013) obtained a production rate of 0.6 mg/L/h
and a maximum content value of 45 mg/L (in YPD medium).
Lower CLA production was expected in strains with nor-
mal β-oxidation activity, such as the Po1d-oPAI WT
(JMY2746) and the Q4-oPAI strain (JMY3473). However, it
was surprising that it was also low in the pox1-6Δ-oPAI strain
(JMY2756). It is possible that the acyltransferases had a high
affinity for OA and were extremely efficient at performing
TAG acylation, which could have resulted in a pool of oleyl
phospholipids that was too small or that remained inaccessible
to the desaturase and isomerase. Regardless of the underlying
mechanisms, in neosynthesis medium, CLA production was
six times greater in the pox1-6Δ-Q3-FAD2-oPAI strain
(JMY3479) than in the other strains. This pattern results from
the strain’s overexpression ofΔ12 desaturase, which resulted
in conversion of OA into LA, and its inability to degrade
lipids. Consequently, LA became freely available to PAI: at
72 h of culture, LA represented 55% of total fatty acids
(Fig. 2b). Previous work has found that Y. lipolytica grown
in glucose medium for the de novo synthesis of fatty acids
preferentially forms LA due to the overexpression of endoge-
nous Δ12 desaturase (Meesters et al. 1996). In this study,
when LAwas present in the medium, all the strains accumu-
lated large amounts of lipids (Fig. 3a). Lipid accumulation in
the pox1-6Δ-oPAI strain (JMY2756) was twice as high as in
the Q4-oPAI strain (JMY3473) or the pox1-6Δ-Q3-FAD2-
oPAI strain (JMY3479). However, biomass and CLA content
(Fig. 3c) was lower in the latter. This strain displayed de-
creased viability after 48 h of culture (data not shown which
could have resulted from the toxic effects of free fatty acids
that were present in higher concentrations in the cell, leading
to cell lysis as observed previously) (Beopoulos et al. 2014,
Dulermo et al. 2014, 2015). Dulermo and Nicaud (2011)
showed that OA-induced cell death in pox1-6Δ and gut2Δ
pox1-6Δ strains overexpressing GPD1 was due to the strains
inability to export fatty acids. CLA production in medium
containing LA was the greatest when the Q4-oPAI strain
(JMY3473) was used, as it could not accumulate fatty acids
as TAGs. It could, however, degrade free fatty acids, which
suggests that it could have efficiently converted free LA into
CLAs.
In this study, the potential bottleneck in CLA production
was the intracellular concentration of LA. We found that, in
the pox1-6Δ-Q3-FAD2-oPAI strain (JMY3479), LA represent-
ed 61% of total fatty acids in cells, as compared to just 33% in
the other strains. However, the relative percentage of CLAs
was only slightly higher in this strain than in the others (6.5 vs.
1.5%; Fig. 2b). A possible explanation is that the LA produced
by Δ12 desaturase is esterified and thus cannot serve as a
substrate for PAI. Because PAI is soluble in the cytoplasm, it
may compete with other cytosolic enzymes for free LA. These
alternative enzymes could create different esterified forms of
LAvia various pathways, such as oxidation or elongation and
thus ultimately restrict the availability of free LA for CLA
production. Previous work has shown that expression of the
Δ12-desaturase gene from Mortierella alpina in
Saccharomyces cerevisiae led to reasonable levels of LA pro-
duction (up to 25% of total fatty acids; Huang et al. 1999).
When Zhang et al. (2013) used theΔ12-desaturase gene from
Mortierella alpina expressed under the control of the hp16d
promoter, the relative percentage of LA was 35.9%.Soybean
oil, which is naturally rich in LA, was efficiently taken up by
Y. lipolytica and then converted to CLAs (Fig. 5a). This ob-
servation suggests that exogenous LA, in contrast to de novo
LA, is a good substrate for PAI (Fig. 5b). Furthermore, CLAs
were detected in the growth medium (Fig. 5c), which could
have resulted from the very high activity levels of intracellular
lipases in Y. lipolytica: hydrolysis of the soybean oil could
have occurred quickly, producing free fatty acids faster than
they could be incorporated into TAGs or other forms of intra-
cellular lipids. Because the pox1-6Δ-Q3-FAD2-oPAI strain
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(JMY3479) could not accumulate lipids as TAGs, the free
fatty acids could be secreted from the cells. This was previ-
ously reported for ricinoleic acid secretion of by Beopoulos
et al. (2014) and by for fatty acid production by Ledesma et al.
(2016). However, genes involved in fatty acid transport into
the cell and genes involved in the secretion of fatty acid re-
mains to be discovered.
We observed that CLA levels decreased after 53 h in the
growth medium and after 96 h in the cells, which suggests that
CLAs were degraded by auxiliary enzymes, forming interme-
diate compounds such as t2t4c6-trienoyl-CoA. Gurvitz et al.
(2001) showed that t10c12-CLA degradat ion in
Saccharomyces cerevisiae requires auxiliary enzymes. An al-
ternative explanation could be the reuptake of the secreted
fatty acid in the late stationary phase as described by
Scharnewski et al. (2008). In cells, CLA degradation occurred
at a rate of 1.8 mg/L/h. In the culture medium, the degradation
rate was also 1.8 mg/L/h between 53 and 72 h of culture but
then subsequently decreased to 0.2 mg/L/h. This pattern could
indicate that the expression or activity of the main auxiliary
enzymes drops after 72 h. Similar CLA degradation dynamics
were observed by Zhang and colleagues. In their study, the
degradation rate was 117 mg/L/h in cells and 95 mg/L/h in the
growth medium (Zhang et al. 2013). This rate is framed by
both the degradation of CLAs in the peroxisome via β-
oxidation and the conversion of CLAs into OA by an auxiliary
enzyme. This fact means that the elimination of β-oxidation
could significantly decrease the CLA degradation rate.
In conclusion, this study has demonstrated the importance
of acyltransferases in lipid accumulation and TAG production.
Although the elimination of TAG synthesis improved CLA
content slightly, lipid content remained low. When TAG syn-
thesis was removed at the same time thatΔ12 desaturase was
overexpressed (in the pox1-6Δ-Q3-FAD2-oPAI strain
[JMY3479]), CLA content was maximal. Nonetheless, lipid
content remained low when neosynthesis medium was used.
In contrast, in bioconversion medium, CLA production was
much greater in the Q4-oPAI strain (JMY3473), which could
not synthesize TAGs.
Deletion of the β-oxidation pathway greatly reduced
CLA degradation; indeed, the rate was even lower than
that achieved in a study by Zhang et al. (2013). However,
some degradation still occurred, probably due to the ac-
tivity of an auxiliary enzyme. When the pox1-6Δ-Q3-
FAD2-oPAI strain (JMY3479) was cultured in the
soybean-oil medium, its CLA production was similar to
that of the strain containing 24 copies of the oPAI gene
created by Zhang et al. (2013).
These results pave the way for further exploration of CLA
production by Y. lipolytica: genetic modifications can be com-
bined with the overexpression of the oPAI gene under a strong
promoter and the deletion of auxiliary enzymes involved in
CLA degradation.
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